Trends in the utilization of BRCA1 and BRCA2 testing after the introduction of a publicly funded genetic testing program
Dossa F, Baxter NN, Sutradhar R, Little T, Velsher L, Lerner-Ellis J, Eisen A, Metcalfe K. Curr Oncol. 2025; 32(8):439.
Dossa F, Baxter NN, Sutradhar R, Little T, Velsher L, Lerner-Ellis J, Eisen A, Metcalfe K. Curr Oncol. 2025; 32(8):439.
Gupta S, Li Q, Nathan P, Kurdyak P, Baxter N, Sutradhar R, Coburn N. Cancer Med. 2025; 14(15):e71096.
Lapinsky SC, Baxter NN, Sutradhar R, Everett K, Porter J, Yudin MH, Shore EM, Berger H, Campbell DM, Snelgrove JW, Simpson AN. Womens Health Issues. 2025; S1049-3867(25)00072-6. E
pub 2025 Jul 8.Ajaj R, Gershon AS, Lau C, Gupta S, Baxter NN, Sutradhar R, Pole JD, Shaikh F, Nathan PC. Int J Cancer. 2025; Jun 24 [Epub ahead of print].
Seyedi P, Aleman D, Baxter N, Bell C, Bodur M, Calzara A, Campbell R, Carter M, de Jager P, Emerson S, Irish J, Martin D, Lee S, Persitz J, Saxe-Braithwaite M, Takata J, Varkul O, Yang S, Zanchetta C, Urbach D. CMAJ. 2025;197(19): E524-E531. Epub 2025 May 19.
Simpson AN, Sutradhar R, McArthur E, Cusimano MC, Baxter NN. BMJ Open. 2024; 14(12):e091312.
Seyedi P, Aleman D, Baxter N, Bell C, Bodur M, Calzavara A, Campbell R, Carter M, de Jager P, Emerson S, Gagliardi A, Irish J, Martin D, Lee S, Saxe-Braithwaite M, Takata J, Yang S, Zanchetta C, Urbach D. Can J Surg. 2024; 67(6):E397-E405.
Ruco A, Lofters AK, Lu H, Baxter NN, Guilcher S, Kopp A, Vahabi M, Datta GD. BMC Cancer. 2024; 24(1):1114.
Sankar A, Stukel TA, Baxter NN, Wijeysundera DN, Hwang SW, Wilton AS, Chan TCY, Sarhangian V, Simpson AN, de Mestral C, Pincus D, Campbell RJ, Urbach DR, Irish J, Gomez D. BJS Open. 2024; 8(4):zrae088.
Campbell RJ, El-Defrawy SR, Bell CM, Urbach DR, Paterson JM, Stukel TA, Gill SS, Irish J, Baxter NN, Gomez D. CMAJ. 2024; 196:E965-72.